EAG Acquires Chemir

Evans Analytical Group, Inc. (EAG), a global provider of surface analysis and materials characterization services, microelectronics “release to production,” and electronic failure analysis services, has acquired Chemir Analytical Services and its affiliates CAS-MI Laboratories and Cyanta Analytical Services.

Evans Analytical Group, Inc. (EAG), a global provider of surface analysis and materials characterization services, microelectronics “release to production,” and electronic failure analysis services, has acquired Chemir Analytical Services and its affiliates CAS-MI Laboratories and Cyanta Analytical Services. Chemir and CAS-MI will continue to operate under their current names, and Cyanta will begin the process to be renamed EAG Life Sciences to reflect its planned expansion of service offerings.  All three laboratories will continue operations at their respective facilities.  Financial terms of the transaction were not disclosed. 

The acquisition allows EAG to better serve the industry-specific needs of its diverse clients, including development of novel coating technologies beyond surface analysis investigations, greater access to industry leading analytical capabilities to determine the source of product failures or help defend a patent infringement case, and access to a worldwide network of laboratories and industry leading surface analysis and materials characterization capabilities to support product development and analytical investigations.  

Chemir Analytical Services of St. Louis, MO, has built its reputation by solving unique challenges associated with product failures across diverse industries including identification of contaminants, deformulation of products and litigation support for patent infringement cases. CAS-MI Laboratories of Ypsilanti, MI, has provided analytical services for the polymer, paints, coatings, adhesives and sealants industries since 1943.  More recently, CAS-MI has assisted entrepreneurs in product development for novel paint and coating technologies.  Cyanta Analytical Services, also of St. Louis, MO, provides services to support pharmaceutical and medical device development.  Cyanta currently specializes in cGMP and GLP analytical services such as stability programs, extractables & leachables, bioanalysis and custom synthesis.

EAG is majority owned by Odyssey Investment Partners, LLC, a leading private equity firm with more than $2 billion in capital under management. Odyssey makes majority, control investments primarily in established middle-market industrial manufacturing and business services companies in a variety of industries. Further information regarding Odyssey Investment Partners can be found at www.odysseyinvestment.com.